Milestone Pharmaceuticals Inc. vs Moolec Science SA — Valuation Comparison 2026
Access all valuation models for MIST vs MLEC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →MIST scores higher with a 3.6/10 quality rating vs MLEC's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing Milestone Pharmaceuticals Inc. (MIST) and Moolec Science SA (MLEC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
MIST currently trades at $1.44 with a QOC of 3.6/10, while MLEC trades at $7.20 with a QOC of 1.7/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).